{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:58:11Z","timestamp":1794581891275,"version":"4.9.1"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40257-025-00996-y","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T14:54:43Z","timestamp":1764600883000},"page":"85-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cardiovascular Imaging in Psoriasis: A Critical Review of Current Evidence, Techniques, and Therapeutic Implications"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8838-7649","authenticated-orcid":false,"given":"Jacopo","family":"Tartaglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Ponzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1588-2061","authenticated-orcid":false,"given":"Roberto","family":"Mazzetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvise","family":"Sernicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9098-4124","authenticated-orcid":false,"given":"Christian","family":"Ciolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Tona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1091-4733","authenticated-orcid":false,"given":"Stefano","family":"Piaserico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"996_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jaad.2008.09.022","volume":"60","author":"SK Kurd","year":"2009","unstructured":"Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol. 2009;60:218\u201324. https:\/\/doi.org\/10.1016\/j.jaad.2008.09.022.","journal-title":"J Am Acad Dermatol"},{"key":"996_CR2","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.jacc.2021.02.009","volume":"77","author":"MS Garshick","year":"2021","unstructured":"Garshick MS, Ward NL, Krueger JG, Berger JS. Cardiovascular risk in patients with psoriasis. J Am Coll Cardiol. 2021;77:1670\u201380. https:\/\/doi.org\/10.1016\/j.jacc.2021.02.009.","journal-title":"J Am Coll Cardiol"},{"key":"996_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000062","volume":"2","author":"EJ Armstrong","year":"2013","unstructured":"Armstrong EJ, Harskamp CT, Armstrong AW. Psoriasis and major adverse cardiovascular events: a systematic review and meta\u2010analysis of observational studies. J Am Heart Assoc. 2013;2:e000062. https:\/\/doi.org\/10.1161\/JAHA.113.000062.","journal-title":"J Am Heart Assoc"},{"key":"996_CR4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1600-0625.2011.01308.x","volume":"20","author":"AW Armstrong","year":"2011","unstructured":"Armstrong AW, Voyles SV, Armstrong EJ, Fuller EN, Rutledge JC. A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis. Exp Dermatol. 2011;20:544\u20139. https:\/\/doi.org\/10.1111\/j.1600-0625.2011.01308.x.","journal-title":"Exp Dermatol"},{"key":"996_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jaad.2018.02.040","volume":"79","author":"B Lockshin","year":"2018","unstructured":"Lockshin B, Balagula Y, Merola JF. Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis. J Am Acad Dermatol. 2018;79:345\u201352. https:\/\/doi.org\/10.1016\/j.jaad.2018.02.040.","journal-title":"J Am Acad Dermatol"},{"key":"996_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.70069","volume":"43","author":"K Yang","year":"2025","unstructured":"Yang K, Liu Q, Fan A, Lin H, Wang X, Cui T, et al. Th17 cells in cardiovascular disease. Cell Biochem Funct. 2025;43:e70069. https:\/\/doi.org\/10.1002\/cbf.70069.","journal-title":"Cell Biochem Funct"},{"key":"996_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","volume":"20","author":"W-H Boehncke","year":"2011","unstructured":"Boehncke W-H, Boehncke S, Tobin A-M, Kirby B. The \u00abpsoriatic march\u00bb: a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol. 2011;20:303\u20137. https:\/\/doi.org\/10.1111\/j.1600-0625.2011.01261.x.","journal-title":"Exp Dermatol"},{"key":"996_CR8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/cvr\/cvz009","volume":"115","author":"YA Elnabawi","year":"2019","unstructured":"Elnabawi YA, Dey AK, Goyal A, Groenendyk JW, Chung JH, Belur AD, et al. Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study. Cardiovasc Res. 2019;115:721\u20138. https:\/\/doi.org\/10.1093\/cvr\/cvz009.","journal-title":"Cardiovasc Res"},{"key":"996_CR9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1159\/000518771","volume":"238","author":"W Bao","year":"2022","unstructured":"Bao W, Yang M, Xu Z, Yan F, Yang Q, Li X, et al. Coronary inflammation assessed by perivascular fat attenuation index in patients with psoriasis: a propensity score-matched study. Dermatology. 2022;238:562\u201370. https:\/\/doi.org\/10.1159\/000518771.","journal-title":"Dermatology"},{"key":"996_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2019.08.009","volume":"289","author":"S Piaserico","year":"2019","unstructured":"Piaserico S, Osto E, Famoso G, Montisci R, De Michieli L, Zanetti I, et al. Long-term prognostic value of coronary flow reserve in psoriasis patients. Atherosclerosis. 2019;289:57\u201363. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.08.009.","journal-title":"Atherosclerosis"},{"key":"996_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-024-02456-9","author":"J Gr\u00f6schel","year":"2024","unstructured":"Gr\u00f6schel J, Grassow L, Blaszczyk E, Lommel K, Kokolakis G, Sabat R, et al. Deep cardiac phenotyping by cardiovascular magnetic resonance reveals subclinical focal and diffuse myocardial injury in patients with psoriasis (PSOR-COR study). Clin Res Cardiol. 2024. https:\/\/doi.org\/10.1007\/s00392-024-02456-9.","journal-title":"Clin Res Cardiol"},{"key":"996_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/ijd.12673","volume":"54","author":"S Seremet","year":"2015","unstructured":"Seremet S, Genc B, Tastan A, Akyildiz ZI, Nazli C, Ozcelik S, et al. Are all patients with psoriasis at increased risk for coronary artery disease? Int J Dermatol. 2015;54:355\u201361. https:\/\/doi.org\/10.1111\/ijd.12673.","journal-title":"Int J Dermatol"},{"key":"996_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2011.12.015","volume":"221","author":"E Osto","year":"2012","unstructured":"Osto E, Piaserico S, Maddalozzo A, Forchetti G, Montisci R, Famoso G, et al. Impaired coronary flow reserve in young patients affected by severe psoriasis. Atherosclerosis. 2012;221:113\u20137. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.12.015.","journal-title":"Atherosclerosis"},{"key":"996_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13711","volume":"52","author":"F Tona","year":"2022","unstructured":"Tona F, Osto E, Kerkhof PLM, Montisci R, Famoso G, Lorenzoni G, et al. Multiparametric analysis of coronary flow in psoriasis using a coronary flow reserve companion. Eur J Clin Invest. 2022;52:e13711. https:\/\/doi.org\/10.1111\/eci.13711.","journal-title":"Eur J Clin Invest"},{"key":"996_CR15","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3752","volume":"101","author":"H Kaiser","year":"2021","unstructured":"Kaiser H, Kvist-Hansen A, Krakauer M, G\u00f8rtz PM, Henningsen KMA, Wang X, et al. Statin therapy and vascular inflammation detected by positron emission tomography\/computed tomography in patients with psoriasis. Acta Derm Venereol. 2021;101:adv00406. https:\/\/doi.org\/10.2340\/00015555-3752.","journal-title":"Acta Derm Venereol"},{"key":"996_CR16","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s12350-019-02000-7","volume":"28","author":"R Green","year":"2021","unstructured":"Green R, Cantoni V, Acampa W, Assante R, Zampella E, Nappi C, et al. Prognostic value of coronary flow reserve in patients with suspected or known coronary artery disease referred to PET myocardial perfusion imaging: a meta-analysis. J Nucl Cardiol. 2021;28:904\u201318. https:\/\/doi.org\/10.1007\/s12350-019-02000-7.","journal-title":"J Nucl Cardiol"},{"key":"996_CR17","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/cvr\/cvz160","volume":"115","author":"BI Levy","year":"2019","unstructured":"Levy BI, Heusch G, Camici PG. The many faces of myocardial ischaemia and angina. Cardiovasc Res. 2019;115:1460\u201370. https:\/\/doi.org\/10.1093\/cvr\/cvz160.","journal-title":"Cardiovasc Res"},{"key":"996_CR18","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1161\/CIRCULATIONAHA.114.009716","volume":"131","author":"VR Taqueti","year":"2015","unstructured":"Taqueti VR, Everett BM, Murthy VL, Gaber M, Foster CR, Hainer J, et al. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation. 2015;131:528\u201335. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.009716.","journal-title":"Circulation"},{"key":"996_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/01.mca.0000134590.99841.81","volume":"15","author":"MB Britten","year":"2004","unstructured":"Britten MB, Zeiher AM, Sch\u00e4chinger V. Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome. Coron Artery Dis. 2004;15:259. https:\/\/doi.org\/10.1097\/01.mca.0000134590.99841.81.","journal-title":"Coron Artery Dis"},{"key":"996_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cjca.2014.11.002","volume":"31","author":"I Ikonomidis","year":"2015","unstructured":"Ikonomidis I, Makavos G, Papadavid E, Varoudi M, Andreadou I, Gravanis K, et al. Similarities in coronary function and myocardial deformation between psoriasis and coronary artery disease: the role of oxidative stress and inflammation. Can J Cardiol. 2015;31:287\u201395. https:\/\/doi.org\/10.1016\/j.cjca.2014.11.002.","journal-title":"Can J Cardiol"},{"key":"996_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac544.2643","volume":"43","author":"I Ikonomidis","year":"2022","unstructured":"Ikonomidis I, Pavlidis G, Katogiannis K, Kapniari I, Theodoropoulos K, Kountouri A, et al. Differences in coronary flow reserve and flow-mediated dilation between plaque psoriasis and psoriatic arthritis. Eur Heart J. 2022;43:ehac544.2643. https:\/\/doi.org\/10.1093\/eurheartj\/ehac544.2643.","journal-title":"Eur Heart J"},{"key":"996_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12471","author":"M Fioranelli","year":"2017","unstructured":"Fioranelli M, Roccia MG, Lotti T. Coronary blood flow and psoriasis. Dermatol Ther. 2017. https:\/\/doi.org\/10.1111\/dth.12471.","journal-title":"Dermatol Ther"},{"key":"996_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2016.05.036","volume":"251","author":"S Piaserico","year":"2016","unstructured":"Piaserico S, Osto E, Famoso G, Zanetti I, Gregori D, Poretto A, et al. Treatment with tumor necrosis factor inhibitors restores coronary microvascular function in young patients with severe psoriasis. Atherosclerosis. 2016;251:25\u201330. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.05.036.","journal-title":"Atherosclerosis"},{"key":"996_CR24","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.jid.2023.02.037","volume":"143","author":"S Piaserico","year":"2023","unstructured":"Piaserico S, Papadavid E, Cecere A, Orlando G, Theodoropoulos K, Katsimbri P, et al. Coronary microvascular dysfunction in asymptomatic patients with severe psoriasis. J Invest Dermatol. 2023;143:1929-1936.e2. https:\/\/doi.org\/10.1016\/j.jid.2023.02.037.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"996_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2024.0618","volume":"86","author":"H Jain","year":"2025","unstructured":"Jain H, Tariq MD, Khan AM, Ahsan A, Zulfiqar E, Shahnoor S, et al. Assessment of subclinical atherosclerosis in patients with psoriasis using echocardiographic coronary flow reserve parameters: a systematic review and meta-analysis. Br J Hosp Med. 2025;86(2):1\u201316. https:\/\/doi.org\/10.12968\/hmed.2024.0618.","journal-title":"Br J Hosp Med"},{"key":"996_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1161\/CIRCULATIONAHA.114.011939","volume":"131","author":"VR Taqueti","year":"2015","unstructured":"Taqueti VR, Hachamovitch R, Murthy VL, Naya M, Foster CR, Hainer J, et al. Global coronary flow reserve associates with adverse cardiovascular events independently of luminal angiographic severity, and modifies the effect of early revascularization. Circulation. 2015;131:19\u201327. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.011939.","journal-title":"Circulation"},{"key":"996_CR27","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/echo.12156","volume":"30","author":"H Gullu","year":"2013","unstructured":"Gullu H, Caliskan M, Dursun R, Ciftci O, Guven A, Muderrisoglu H. Impaired coronary microvascular function and its association with disease duration and inflammation in patients with psoriasis. Echocardiography. 2013;30:912\u20138. https:\/\/doi.org\/10.1111\/echo.12156.","journal-title":"Echocardiography"},{"key":"996_CR28","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00403-015-1586-7","volume":"307","author":"S Milaniuk","year":"2015","unstructured":"Milaniuk S, Pietrzak A, Mosiewicz B, Mosiewicz J, Reich K. Influence of psoriasis on circulatory system function assessed in echocardiography. Arch Dermatol Res. 2015;307:855\u201361. https:\/\/doi.org\/10.1007\/s00403-015-1586-7.","journal-title":"Arch Dermatol Res"},{"key":"996_CR29","doi-asserted-by":"publisher","first-page":"934","DOI":"10.4081\/monaldi.2018.934","volume":"88","author":"E Gorga","year":"2018","unstructured":"Gorga E, Scodro M, Valentini F, D\u2019Ortona R, Arisi M, Sciatti E, et al. Echocardiographic evaluation of diastolic dysfunction in young and healthy patients with psoriasis: a case\u2013control study. Monaldi Arch Chest Dis Arch Monaldi Mal Torace. 2018;88:934. https:\/\/doi.org\/10.4081\/monaldi.2018.934.","journal-title":"Monaldi Arch Chest Dis Arch Monaldi Mal Torace."},{"key":"996_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7583690","volume":"2019","author":"M Mocan","year":"2019","unstructured":"Mocan M, Mocan Hognogi LD, Anton FP, Chiorescu RM, Goidescu CM, Stoia MA, et al. Biomarkers of inflammation in left ventricular diastolic dysfunction. Dis Markers. 2019;2019:7583690. https:\/\/doi.org\/10.1155\/2019\/7583690.","journal-title":"Dis Markers"},{"key":"996_CR31","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/ejhf.1902","volume":"22","author":"M Packer","year":"2020","unstructured":"Packer M, Lam CSP, Lund LH, Maurer MS, Borlaug BA. Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease. Eur J Heart Fail. 2020;22:1551\u201367. https:\/\/doi.org\/10.1002\/ejhf.1902.","journal-title":"Eur J Heart Fail"},{"key":"996_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tsch\u00f6pe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62:263\u201371. https:\/\/doi.org\/10.1016\/j.jacc.2013.02.092.","journal-title":"J Am Coll Cardiol"},{"key":"996_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/clc.70047","volume":"47","author":"H Jain","year":"2024","unstructured":"Jain H, Jain J, Dey D, Modi R, Alomari O, Ahmed M, et al. Subclinical myocardial dysfunction assessment using speckle tracking echocardiography in patients with psoriasis: a pilot meta-analysis. Clin Cardiol. 2024;47:e70047. https:\/\/doi.org\/10.1002\/clc.70047.","journal-title":"Clin Cardiol"},{"key":"996_CR34","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1177\/147323000603400608","volume":"34","author":"I Biyik","year":"2006","unstructured":"Biyik I, Narin A, Bozok MA, Ergene O. Echocardiographic and clinical abnormalities in patients with psoriasis. J Int Med Res. 2006;34:632\u20139. https:\/\/doi.org\/10.1177\/147323000603400608.","journal-title":"J Int Med Res"},{"key":"996_CR35","doi-asserted-by":"publisher","first-page":"039463202211111","DOI":"10.1177\/03946320221111131","volume":"36","author":"H Midtb\u00f8","year":"2022","unstructured":"Midtb\u00f8 H, Kringeland E, Gerdts E, Ueland PM, Meyer K, Linde A, et al. Biomarkers of inflammation and left ventricular remodelling in psoriasis patients treated with infliximab. Int J Immunopathol Pharmacol. 2022;36:03946320221111131. https:\/\/doi.org\/10.1177\/03946320221111131.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"996_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000354726","volume":"228","author":"ZI Akyildiz","year":"2014","unstructured":"Akyildiz ZI, Seremet S, Emren V, Ozcelik S, Gediz B, Tastan A, et al. Epicardial fat thickness is independently associated with psoriasis. Dermatol. 2014;228:55\u20139. https:\/\/doi.org\/10.1159\/000354726.","journal-title":"Dermatol"},{"key":"996_CR37","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/bjd.12569","volume":"169","author":"B Bulbul Sen","year":"2013","unstructured":"Bulbul Sen B, Atci N, Rifaioglu EN, Ekiz O, Kartal I, Buyukkaya E, et al. Increased epicardial fat tissue is a marker of subclinical atherosclerosis in patients with psoriasis. Br J Dermatol. 2013;169:1081\u20136. https:\/\/doi.org\/10.1111\/bjd.12569.","journal-title":"Br J Dermatol"},{"key":"996_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5543\/tkda.2014.78949","volume":"42","author":"A Bacaks\u0131z","year":"2014","unstructured":"Bacaks\u0131z A, Tasal A, Sevgili E, Erdo\u011fan E, Onsun N, S\u00f6nmez O, et al. Epicardial fat thickness in patients with psoriasis vulgaris. Turk Kardiyol Dernegi Arsivi Turk Kardiyol Derneginin Yayin Organidir. 2014;42:47\u201354. https:\/\/doi.org\/10.5543\/tkda.2014.78949.","journal-title":"Turk Kardiyol Dernegi Arsivi Turk Kardiyol Derneginin Yayin Organidir."},{"key":"996_CR39","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1093\/eurheartj\/ehv185","volume":"36","author":"U Khalid","year":"2015","unstructured":"Khalid U, Ahlehoff O, Gislason GH, Skov L, Torp-Pedersen C, Hansen PR. Increased risk of aortic valve stenosis in patients with psoriasis: a nationwide cohort study. Eur Heart J. 2015;36:2177\u201383. https:\/\/doi.org\/10.1093\/eurheartj\/ehv185.","journal-title":"Eur Heart J"},{"key":"996_CR40","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/ehjqcco\/qcae096","volume":"11","author":"Z Wang","year":"2025","unstructured":"Wang Z, Lv J, Zhao S, Yin Z, Shi W, Feng D, et al. Psoriasis and risk of new-onset degenerative valvular heart disease: a prospective cohort study. Eur Heart J Qual Care Clin Outcomes. 2025;11:554\u201364. https:\/\/doi.org\/10.1093\/ehjqcco\/qcae096.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"996_CR41","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/eurheartj\/ehp470","volume":"31","author":"S Achenbach","year":"2010","unstructured":"Achenbach S, Marwan M, Ropers D, Schepis T, Pflederer T, Anders K, et al. Coronary computed tomography angiography with a consistent dose below 1 mSv using prospectively electrocardiogram-triggered high-pitch spiral acquisition. Eur Heart J. 2010;31:340\u20136. https:\/\/doi.org\/10.1093\/eurheartj\/ehp470.","journal-title":"Eur Heart J"},{"key":"996_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jcct.2021.06.003","volume":"16","author":"NH Patel","year":"2022","unstructured":"Patel NH, Dey AK, Sorokin AV, Teklu M, Petrole R, Zhou W, et al. Chronic inflammatory diseases and coronary heart disease: insights from cardiovascular CT. J Cardiovasc Comput Tomogr. 2022;16:7\u201318. https:\/\/doi.org\/10.1016\/j.jcct.2021.06.003.","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"996_CR43","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/ATVBAHA.113.302642","volume":"34","author":"F Otsuka","year":"2014","unstructured":"Otsuka F, Sakakura K, Yahagi K, Joner M, Virmani R. Has our understanding of calcification in human coronary atherosclerosis progressed? Arterioscler Thromb Vasc Biol. 2014;34:724\u201336. https:\/\/doi.org\/10.1161\/ATVBAHA.113.302642.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"996_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12237212","volume":"12","author":"G Napoli","year":"2023","unstructured":"Napoli G, Pergola V, Basile P, De Feo D, Bertrandino F, Baggiano A, et al. Epicardial and pericoronary adipose tissue, coronary inflammation, and acute coronary syndromes. J Clin Med. 2023;12:7212. https:\/\/doi.org\/10.3390\/jcm12237212.","journal-title":"J Clin Med"},{"key":"996_CR45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/CIRCULATIONAHA.116.026859","volume":"136","author":"JB Lerman","year":"2017","unstructured":"Lerman JB, Joshi AA, Chaturvedi A, Aberra TM, Dey AK, Rodante JA, et al. Coronary plaque characterization in psoriasis reveals high-risk features that improve after treatment in a prospective observational study. Circulation. 2017;136:263\u201376. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.026859.","journal-title":"Circulation"},{"key":"996_CR46","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/jamacardio.2018.2769","volume":"3","author":"AA Joshi","year":"2018","unstructured":"Joshi AA, Lerman JB, Dey AK, Sajja AP, Belur AD, Elnabawi YA, et al. Association between aortic vascular inflammation and coronary artery plaque characteristics in psoriasis. JAMA Cardiol. 2018;3:949\u201356. https:\/\/doi.org\/10.1001\/jamacardio.2018.2769.","journal-title":"JAMA Cardiol"},{"key":"996_CR47","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1159\/000502138","volume":"235","author":"H Kaiser","year":"2019","unstructured":"Kaiser H, Abdulla J, Henningsen KMA, Skov L, Hansen PR. Coronary artery disease assessed by computed tomography in patients with psoriasis: a systematic review and meta-analysis. Dermatol. 2019;235:478\u201387. https:\/\/doi.org\/10.1159\/000502138.","journal-title":"Dermatol"},{"key":"996_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s12350-020-02166-5","volume":"29","author":"B Weber","year":"2022","unstructured":"Weber B, Perez-Chada LM, Divakaran S, Brown JM, Taqueti V, Dorbala S, et al. Coronary microvascular dysfunction in patients with psoriasis. J Nucl Cardiol. 2022;29:37\u201342. https:\/\/doi.org\/10.1007\/s12350-020-02166-5.","journal-title":"J Nucl Cardiol"},{"key":"996_CR49","doi-asserted-by":"publisher","first-page":"1044117","DOI":"10.3389\/fcvm.2022.1044117","volume":"9","author":"H Wu","year":"2022","unstructured":"Wu H, Luo Z, Liu J, Luo D, Song L, Zhao Y. Association between psoriasis and coronary artery calcification: a systematic review and meta-analysis. Front Cardiovasc Med. 2022;9:1044117. https:\/\/doi.org\/10.3389\/fcvm.2022.1044117.","journal-title":"Front Cardiovasc Med"},{"key":"996_CR50","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ijcard.2018.09.089","volume":"278","author":"AM Ansaldo","year":"2019","unstructured":"Ansaldo AM, Montecucco F, Sahebkar A, Dallegri F, Carbone F. Epicardial adipose tissue and cardiovascular diseases. Int J Cardiol. 2019;278:254\u201360. https:\/\/doi.org\/10.1016\/j.ijcard.2018.09.089.","journal-title":"Int J Cardiol"},{"key":"996_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20732","volume":"9","author":"R O\u2019Hagan","year":"2023","unstructured":"O\u2019Hagan R, Hsu L-Y, Li H, Hong CG, Parel PM, Berg AR, et al. Longitudinal association of epicardial and thoracic adipose tissues with coronary and cardiac characteristics in psoriasis. Heliyon. 2023;9:e20732. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20732.","journal-title":"Heliyon."},{"key":"996_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13164761","volume":"13","author":"X Chen","year":"2024","unstructured":"Chen X, Xiang H, Lu J, Yang M. Epicardial adipose tissue and psoriasis: a systematic review and meta-analysis. J Clin Med. 2024;13:4761. https:\/\/doi.org\/10.3390\/jcm13164761.","journal-title":"J Clin Med"},{"key":"996_CR53","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jcmg.2021.02.026","volume":"14","author":"PA van Diemen","year":"2021","unstructured":"van Diemen PA, Bom MJ, Driessen RS, Schumacher SP, Everaars H, de Winter RW, et al. Prognostic value of RCA pericoronary adipose tissue CT-attenuation beyond high-risk plaques, plaque volume, and ischemia. JACC Cardiovasc Imaging. 2021;14:1598\u2013610. https:\/\/doi.org\/10.1016\/j.jcmg.2021.02.026.","journal-title":"JACC Cardiovasc Imaging"},{"key":"996_CR54","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jacc.2022.12.021","volume":"81","author":"N Tan","year":"2023","unstructured":"Tan N, Dey D, Marwick TH, Nerlekar N. Pericoronary adipose tissue as a marker of cardiovascular risk: JACC review topic of the week. J Am Coll Cardiol. 2023;81:913\u201323. https:\/\/doi.org\/10.1016\/j.jacc.2022.12.021.","journal-title":"J Am Coll Cardiol"},{"key":"996_CR55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1530\/EDM-23-0017","volume":"2023","author":"AE Malavazos","year":"2023","unstructured":"Malavazos AE, Meregalli C, Sorrentino F, Vignati A, Dubini C, Scravaglieri V, et al. Semaglutide therapy decreases epicardial fat inflammation and improves psoriasis severity in patients affected by abdominal obesity and type-2 diabetes. Endocrinol Diabetes Metab Case Rep. 2023;2023:23\u20130017. https:\/\/doi.org\/10.1530\/EDM-23-0017.","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"996_CR56","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/jamacardio.2019.2589","volume":"4","author":"YA Elnabawi","year":"2019","unstructured":"Elnabawi YA, Oikonomou EK, Dey AK, Mancio J, Rodante JA, Aksentijevich M, et al. Association of biologic therapy with coronary inflammation in patients with psoriasis as assessed by perivascular fat attenuation index. JAMA Cardiol. 2019;4:885\u201391. https:\/\/doi.org\/10.1001\/jamacardio.2019.2589.","journal-title":"JAMA Cardiol"},{"key":"996_CR57","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12410-017-9401-9","volume":"10","author":"A Chaturvedi","year":"2017","unstructured":"Chaturvedi A, Dey AK, Joshi AA, Mehta NN. Vascular inflammation imaging in psoriasis. Curr Cardiovasc Imaging Rep. 2017;10:4. https:\/\/doi.org\/10.1007\/s12410-017-9401-9.","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"996_CR58","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1161\/CIRCULATIONAHA.106.652313","volume":"117","author":"K Aziz","year":"2008","unstructured":"Aziz K, Berger K, Claycombe K, Huang R, Patel R, Abela GS. Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography\/positron emission tomography. Circulation. 2008;117:2061\u201370. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.652313.","journal-title":"Circulation"},{"key":"996_CR59","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.nuclcard.2007.10.009","volume":"15","author":"B Paulmier","year":"2008","unstructured":"Paulmier B, Duet M, Khayat R, Pierquet-Ghazzar N, Laissy J-P, Maunoury C, et al. Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J Nucl Cardiol. 2008;15:209\u201317. https:\/\/doi.org\/10.1016\/j.nuclcard.2007.10.009.","journal-title":"J Nucl Cardiol"},{"key":"996_CR60","first-page":"265","volume":"10","author":"E Kothekar","year":"2020","unstructured":"Kothekar E, Revheim M-E, Borja AJ, Hancin EC, Detchou DK, Werner TJ, et al. Utility of FDG-PET\/CT in clinical psoriasis grading: the PET\u2013PASI scoring system. Am J Nucl Med Mol Imaging. 2020;10:265\u201371.","journal-title":"Am J Nucl Med Mol Imaging."},{"key":"996_CR61","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/archdermatol.2011.119","volume":"147","author":"NN Mehta","year":"2011","unstructured":"Mehta NN, Yu Y, Saboury B, Foroughi N, Krishnamoorthy P, Raper A, et al. Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET\/CT): a pilot study. Arch Dermatol. 2011;147:1031\u20139. https:\/\/doi.org\/10.1001\/archdermatol.2011.119.","journal-title":"Arch Dermatol"},{"key":"996_CR62","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1161\/ATVBAHA.115.306460","volume":"35","author":"HB Naik","year":"2015","unstructured":"Naik HB, Natarajan B, Stansky E, Ahlman MA, Teague H, Salahuddin T, et al. Severity of psoriasis associates with aortic vascular inflammation detected by FDG PET\/CT and neutrophil activation in a prospective observational study. Arterioscler Thromb Vasc Biol. 2015;35:2667\u201376. https:\/\/doi.org\/10.1161\/ATVBAHA.115.306460.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"996_CR63","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/life11040305","volume":"11","author":"H Kaiser","year":"2021","unstructured":"Kaiser H, Kvist-Hansen A, Krakauer M, G\u00f8rtz PM, Henningsen KMA, Wang X, et al. Association between vascular inflammation and inflammation in adipose tissue, spleen, and bone marrow in patients with psoriasis. Life. 2021;11:305. https:\/\/doi.org\/10.3390\/life11040305.","journal-title":"Life"},{"key":"996_CR64","first-page":"273","volume":"3","author":"S Rose","year":"2013","unstructured":"Rose S, Sheth NH, Baker JF, Ogdie A, Raper A, Saboury B, et al. A comparison of vascular inflammation in psoriasis, rheumatoid arthritis, and healthy subjects by FDG-PET\/CT: a pilot study. Am J Cardiovasc Dis. 2013;3:273\u20138.","journal-title":"Am J Cardiovasc Dis"},{"key":"996_CR65","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1007\/s00259-019-04454-w","volume":"46","author":"JW Groenendyk","year":"2019","unstructured":"Groenendyk JW, Shukla P, Dey AK, Elnabawi YA, Aksentijevich M, Choi H, et al. Association of aortic vascular uptake of 18FDG by PET\/CT and aortic wall thickness by MRI in psoriasis: a prospective observational study. Eur J Nucl Med Mol Imaging. 2019;46:2488\u201395. https:\/\/doi.org\/10.1007\/s00259-019-04454-w.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"996_CR66","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ahj.2013.07.010","volume":"166","author":"CS Crowson","year":"2013","unstructured":"Crowson CS, Liao KP, Davis JM, Solomon DH, Matteson EL, Knutson KL, et al. Rheumatoid arthritis and cardiovascular disease. Am Heart J. 2013;166:622-628.e1. https:\/\/doi.org\/10.1016\/j.ahj.2013.07.010.","journal-title":"Am Heart J"},{"key":"996_CR67","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/rheumatology\/ken466","volume":"48","author":"F Montecucco","year":"2009","unstructured":"Montecucco F, Burger F, Pelli G, Poku NK, Berlier C, Steffens S, et al. Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes. Rheumatology. 2009;48:233\u201342. https:\/\/doi.org\/10.1093\/rheumatology\/ken466.","journal-title":"Rheumatology"},{"key":"996_CR68","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1007\/s12350-023-03204-8","volume":"30","author":"KE Boczar","year":"2023","unstructured":"Boczar KE, Beanlands RS, Glassman SJ, Wang J, Zeng W, deKemp RA, et al. Anti-inflammatory effect of biologic therapy in patients with psoriatic disease: a prospective cohort FDG PET study. J Nucl Cardiol. 2023;30:1642\u201352. https:\/\/doi.org\/10.1007\/s12350-023-03204-8.","journal-title":"J Nucl Cardiol"},{"key":"996_CR69","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.jid.2017.02.977","volume":"137","author":"R Bissonnette","year":"2017","unstructured":"Bissonnette R, Harel F, Krueger JG, Guertin M-C, Chabot-Blanchet M, Gonzalez J, et al. TNF-\u03b1 antagonist and vascular inflammation in patients with psoriasis\u00a0vulgaris: a randomized placebo-controlled study. J Invest Dermatol. 2017;137:1638\u201345. https:\/\/doi.org\/10.1016\/j.jid.2017.02.977.","journal-title":"J Invest Dermatol"},{"key":"996_CR70","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.jid.2017.05.034","volume":"137","author":"KF Hjuler","year":"2017","unstructured":"Hjuler KF, Gormsen LC, Iversen L. Using FDG-PET\/CT to detect vascular inflammation in patients with psoriasis: where to look? And for what?? J Invest Dermatol. 2017;137:2236\u20137. https:\/\/doi.org\/10.1016\/j.jid.2017.05.034.","journal-title":"J Invest Dermatol"},{"key":"996_CR71","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/bjd.15149","volume":"176","author":"KF Hjuler","year":"2017","unstructured":"Hjuler KF, Gormsen LC, Vendelbo MH, Egeberg A, Nielsen J, Iversen L. Increased global arterial and subcutaneous adipose tissue inflammation in patients with moderate-to-severe psoriasis. Br J Dermatol. 2017;176:732\u201340. https:\/\/doi.org\/10.1111\/bjd.15149.","journal-title":"Br J Dermatol"},{"key":"996_CR72","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1001\/jamadermatol.2022.3862","volume":"158","author":"JM Gelfand","year":"2022","unstructured":"Gelfand JM, Shin DB, Armstrong AW, Tyring SK, Blauvelt A, Gottlieb S, et al. Association of apremilast with vascular inflammation and cardiometabolic function in patients with psoriasis: the VIP-A phase 4, open-label, nonrandomized clinical trial. JAMA Dermatol. 2022;158:1394\u2013403. https:\/\/doi.org\/10.1001\/jamadermatol.2022.3862.","journal-title":"JAMA Dermatol"},{"key":"996_CR73","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.jaad.2018.03.011","volume":"80","author":"B-S Kim","year":"2019","unstructured":"Kim B-S, Lee W-K, Pak K, Han J, Kim G-W, Kim H-S, et al. Ustekinumab treatment is associated with decreased systemic and vascular inflammation in patients with moderate-to-severe psoriasis: feasibility study using 18F-fluorodeoxyglucose PET\/CT. J Am Acad Dermatol. 2019;80:1322\u201331. https:\/\/doi.org\/10.1016\/j.jaad.2018.03.011.","journal-title":"J Am Acad Dermatol"},{"key":"996_CR74","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jid.2019.07.679","volume":"140","author":"JM Gelfand","year":"2020","unstructured":"Gelfand JM, Shin DB, Alavi A, Torigian DA, Werner T, Papadopoulos M, et al. A phase IV, randomized, double-blind, placebo-controlled crossover study of the effects of ustekinumab on vascular inflammation in psoriasis (the VIP-U Trial). J Invest Dermatol. 2020;140:85-93.e2. https:\/\/doi.org\/10.1016\/j.jid.2019.07.679.","journal-title":"J Invest Dermatol"},{"key":"996_CR75","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.jid.2020.01.025","volume":"140","author":"JM Gelfand","year":"2020","unstructured":"Gelfand JM, Shin DB, Duffin KC, Armstrong AW, Blauvelt A, Tyring SK, et al. A randomized placebo-controlled trial of secukinumab on aortic vascular inflammation in moderate-to-severe plaque psoriasis (VIP-S). J Invest Dermatol. 2020;140:1784-1793.e2. https:\/\/doi.org\/10.1016\/j.jid.2020.01.025.","journal-title":"J Invest Dermatol"},{"key":"996_CR76","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","volume":"72","author":"VM Ferreira","year":"2018","unstructured":"Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72:3158\u201376. https:\/\/doi.org\/10.1016\/j.jacc.2018.09.072.","journal-title":"J Am Coll Cardiol"},{"key":"996_CR77","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s10554-022-02571-6","volume":"38","author":"M Fenski","year":"2022","unstructured":"Fenski M, Grandy TH, Viezzer D, Kertusha S, Schmidt M, Forman C, et al. Isotropic 3D compressed sensing (CS) based sequence is comparable to 2D-LGE in left ventricular scar quantification in different disease entities. Int J Cardiovasc Imaging. 2022;38:1837\u201350. https:\/\/doi.org\/10.1007\/s10554-022-02571-6.","journal-title":"Int J Cardiovasc Imaging"},{"key":"996_CR78","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.jacc.2017.12.020","volume":"71","author":"VO Puntmann","year":"2018","unstructured":"Puntmann VO, Carr-White G, Jabbour A, Yu C-Y, Gebker R, Kelle S, et al. Native T1 and ECV of noninfarcted myocardium and outcome in patients with coronary artery disease. J Am Coll Cardiol. 2018;71:766\u201378. https:\/\/doi.org\/10.1016\/j.jacc.2017.12.020.","journal-title":"J Am Coll Cardiol"},{"key":"996_CR79","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jcmg.2014.12.025","volume":"8","author":"NAB Ntusi","year":"2015","unstructured":"Ntusi NAB, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD, et al. Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping. JACC Cardiovasc Imaging. 2015;8:526\u201336. https:\/\/doi.org\/10.1016\/j.jcmg.2014.12.025.","journal-title":"JACC Cardiovasc Imaging"},{"key":"996_CR80","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1002\/art.40671","volume":"70","author":"Q Guo","year":"2018","unstructured":"Guo Q, Wu L-M, Wang Z, Shen J-Y, Su X, Wang C-Q, et al. Early detection of silent myocardial impairment in drug-naive patients with new-onset systemic lupus erythematosus: a three-center prospective study. Arthritis Rheumatol. 2018;70:2014\u201324. https:\/\/doi.org\/10.1002\/art.40671.","journal-title":"Arthritis Rheumatol"},{"key":"996_CR81","doi-asserted-by":"publisher","first-page":"e606","DOI":"10.1111\/jdv.16486","volume":"34","author":"M Goldenberg","year":"2020","unstructured":"Goldenberg M, Reynolds M, Smart S, Kaffenberger J, Raman SV, Kaffenberger BH. A retrospective study of myocardial abnormalities detected on cardiac magnetic resonance imaging among patients with psoriasis compared to inflammatory skin disease controls. J Eur Acad Dermatol Venereol. 2020;34:e606\u20138. https:\/\/doi.org\/10.1111\/jdv.16486.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"996_CR82","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"DR Messroghli","year":"2017","unstructured":"Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson. 2017;19:75. https:\/\/doi.org\/10.1186\/s12968-017-0389-8.","journal-title":"J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson."},{"key":"996_CR83","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/art.22530","volume":"57","author":"C Gonzalez-Juanatey","year":"2007","unstructured":"Gonzalez-Juanatey C, Llorca J, Miranda-Filloy JA, Amigo-Diaz E, Testa A, Garcia-Porrua C, et al. Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum. 2007;57:287\u201393. https:\/\/doi.org\/10.1002\/art.22530.","journal-title":"Arthritis Rheum"},{"key":"996_CR84","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/bjd.12355","volume":"169","author":"EA Dowlatshahi","year":"2013","unstructured":"Dowlatshahi EA, van der Voort EaM, Arends LR, Nijsten T. Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2013;169:266\u201382. https:\/\/doi.org\/10.1111\/bjd.12355.","journal-title":"Br J Dermatol"},{"key":"996_CR85","first-page":"877","volume":"35","author":"L Eder","year":"2008","unstructured":"Eder L, Zisman D, Barzilai M, Laor A, Rahat M, Rozenbaum M, et al. Subclinical atherosclerosis in psoriatic arthritis: a case\u2013control study. J Rheumatol. 2008;35:877\u201382.","journal-title":"J Rheumatol"},{"key":"996_CR86","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00059-011-3547-z","volume":"37","author":"B Enany","year":"2012","unstructured":"Enany B, El Zohiery AK, Elhilaly R, Badr T. Carotid intima-media thickness and serum leptin in psoriasis. Herz. 2012;37:527\u201333. https:\/\/doi.org\/10.1007\/s00059-011-3547-z.","journal-title":"Herz"},{"key":"996_CR87","doi-asserted-by":"publisher","first-page":"286","DOI":"10.5114\/ada.2016.61605","volume":"33","author":"K Ba\u0144ska-Kisiel","year":"2016","unstructured":"Ba\u0144ska-Kisiel K, Haberka M, Bergler-Czop B, Brzezi\u0144ska-Wcis\u0142o L, Okopie\u0144 B, G\u0105sior Z. Carotid intima-media thickness in patients with mild or moderate psoriasis. Postepy Dermatol Alergol. 2016;33:286\u20139. https:\/\/doi.org\/10.5114\/ada.2016.61605.","journal-title":"Postepy Dermatol Alergol"},{"key":"996_CR88","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00403-024-03625-6","volume":"317","author":"L Ji","year":"2024","unstructured":"Ji L, Ravi S, Wright L, Nguyen V, Wiley J, Vukelic M, et al. Psoriasis treatments in the stabilization of atherosclerosis: a systematic review. Arch Dermatol Res. 2024;317:159. https:\/\/doi.org\/10.1007\/s00403-024-03625-6.","journal-title":"Arch Dermatol Res"},{"key":"996_CR89","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3390\/life11090919","volume":"11","author":"\u00c9A Piros","year":"2021","unstructured":"Piros \u00c9A, Szab\u00f3 \u00c1, Rencz F, Brodszky V, Szalai K, Galajda N, et al. Impact of interleukin-17 inhibitor therapy on arterial intima-media thickness among severe psoriatic patients. Life. 2021;11:919. https:\/\/doi.org\/10.3390\/life11090919.","journal-title":"Life"},{"key":"996_CR90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211808","volume":"14","author":"A Gonzalez-Cantero","year":"2019","unstructured":"Gonzalez-Cantero A, Gonzalez-Cantero J, Sanchez-Moya AI, Perez-Hortet C, Arias-Santiago S, Schoendorff-Ortega C, et al. Subclinical atherosclerosis in psoriasis. Usefulness of femoral artery ultrasound for the diagnosis, and analysis of its relationship with insulin resistance. PLoS ONE. 2019;14:e0211808. https:\/\/doi.org\/10.1371\/journal.pone.0211808.","journal-title":"PLoS ONE"},{"key":"996_CR91","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jaad.2018.07.007","volume":"80","author":"A Gonz\u00e1lez-Cantero","year":"2019","unstructured":"Gonz\u00e1lez-Cantero A, Gonzalez-Cantero J, Sanchez-Moya AI, Perez-Hortet C, Arias-Santiago S, Martin-Rodriguez JL, et al. Femoral artery ultrasound for improving the detection of atherosclerosis in psoriasis. J Am Acad Dermatol. 2019;80:784\u20136. https:\/\/doi.org\/10.1016\/j.jaad.2018.07.007.","journal-title":"J Am Acad Dermatol"},{"key":"996_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2018.00064","volume":"5","author":"VVS Bonarjee","year":"2018","unstructured":"Bonarjee VVS. Arterial stiffness: a prognostic marker in coronary heart disease. Available methods and clinical application. Front Cardiovasc Med. 2018;5:64. https:\/\/doi.org\/10.3389\/fcvm.2018.00064.","journal-title":"Front Cardiovasc Med"},{"key":"996_CR93","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1097\/HJH.0000000000002081","volume":"37","author":"A Milan","year":"2019","unstructured":"Milan A, Zocaro G, Leone D, Tosello F, Buraioli I, Schiavone D, et al. Current assessment of pulse wave velocity: comprehensive review of validation studies. J Hypertens. 2019;37:1547\u201357. https:\/\/doi.org\/10.1097\/HJH.0000000000002081.","journal-title":"J Hypertens"},{"key":"996_CR94","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000182256","volume":"218","author":"P Gisondi","year":"2008","unstructured":"Gisondi P, Fantin F, Del Giglio M, Valbusa F, Marino F, Zamboni M, et al. Chronic plaque psoriasis is associated with increased arterial stiffness. Dermatology. 2008;218:110\u20133. https:\/\/doi.org\/10.1159\/000182256.","journal-title":"Dermatology"},{"key":"996_CR95","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oead016","volume":"3","author":"G Makavos","year":"2023","unstructured":"Makavos G, Ikonomidis I, Lambadiari V, Koliou G-A, Pavlidis G, Thymis J, et al. Additive prognostic value of longitudinal myocardial deformation to SCORE2 in psoriasis. Eur Heart J Open. 2023;3:oead016. https:\/\/doi.org\/10.1093\/ehjopen\/oead016.","journal-title":"Eur Heart J Open"},{"key":"996_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2024.07.013","author":"L Agoglia","year":"2025","unstructured":"Agoglia L, Peixoto H, Cardoso AC, Barbosa L, Victer CSXL, Carneiro S, et al. Psoriasis and cardiovascular risk: associated and protective factors. An Bras Dermatol. 2025. https:\/\/doi.org\/10.1016\/j.abd.2024.07.013.","journal-title":"An Bras Dermatol"},{"key":"996_CR97","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/HYPERTENSIONAHA.109.143982","volume":"55","author":"K Angel","year":"2010","unstructured":"Angel K, Provan SA, Gulseth HL, Mowinckel P, Kvien TK, Atar D. Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study. Hypertension Dallas Tex 1979. 2010;55:333\u20138. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.143982.","journal-title":"Hypertension Dallas Tex 1979"},{"key":"996_CR98","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/bjd.14076","volume":"173","author":"E Cohen-Barak","year":"2015","unstructured":"Cohen-Barak E, Sah M, Kerner M, Rozenman D, Ziv M. Impact of antipsoriatic therapy on endothelial function. Br J Dermatol. 2015;173:1440\u20136. https:\/\/doi.org\/10.1111\/bjd.14076.","journal-title":"Br J Dermatol"},{"key":"996_CR99","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/ijd.14200","volume":"58","author":"M Nakao","year":"2019","unstructured":"Nakao M, Nakamura K, Fukasawa T, Shida R, Ito A, Ichimura Y, et al. Assessment of endothelial function during the loading phase of infliximab in psoriasis: a potential predictor of its drug survival. Int J Dermatol. 2019;58:54\u20139. https:\/\/doi.org\/10.1111\/ijd.14200.","journal-title":"Int J Dermatol"},{"key":"996_CR100","doi-asserted-by":"publisher","first-page":"158","DOI":"10.55563\/clinexprheumatol\/3qiqk3","volume":"39","author":"A Ortolan","year":"2021","unstructured":"Ortolan A, Ramonda R, Lorenzin M, Pesavento R, Spinazz\u00e8 A, Felicetti M, et al. Subclinical atherosclerosis evolution during 5 years of anti-TNF-alpha treatment in psoriatic arthritis patients. Clin Exp Rheumatol. 2021;39:158\u201361. https:\/\/doi.org\/10.55563\/clinexprheumatol\/3qiqk3.","journal-title":"Clin Exp Rheumatol"},{"key":"996_CR101","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jid.2018.10.042","volume":"139","author":"E von Stebut","year":"2019","unstructured":"von Stebut E, Reich K, Tha\u00e7i D, Koenig W, Pinter A, K\u00f6rber A, et al. Impact of secukinumab on endothelial dysfunction and other cardiovascular disease parameters in psoriasis patients over 52 weeks. J Invest Dermatol. 2019;139:1054\u201362. https:\/\/doi.org\/10.1016\/j.jid.2018.10.042.","journal-title":"J Invest Dermatol"},{"key":"996_CR102","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/j.jacc.2023.03.410","volume":"81","author":"DE Winchester","year":"2023","unstructured":"Multimodality Writing Group for Chronic Coronary Disease, Winchester DE, Maron DJ, Blankstein R, Chang IC, Kirtane AJ, et al. ACC\/AHA\/ASE\/ASNC\/ASPC\/HFSA\/HRS\/SCAI\/SCCT\/SCMR\/STS 2023 multimodality appropriate use criteria for the detection and risk assessment of chronic coronary disease. J Am Coll Cardiol. 2023;81:2445\u201367. https:\/\/doi.org\/10.1016\/j.jacc.2023.03.410.","journal-title":"J Am Coll Cardiol"},{"key":"996_CR103","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227\u2013337. https:\/\/doi.org\/10.1093\/eurheartj\/ehab484.","journal-title":"Eur Heart J"},{"key":"996_CR104","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1161\/CIR.0000000000000678","volume":"140","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596-646. https:\/\/doi.org\/10.1161\/CIR.0000000000000678.","journal-title":"Circulation"},{"key":"996_CR105","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/eurjpc\/zwaa033","volume":"29","author":"A Gonzalez-Cantero","year":"2022","unstructured":"Gonzalez-Cantero A, Reddy AS, Dey AK, Gonzalez-Cantero J, Munger E, Rodante J, et al. Underperformance of clinical risk scores in identifying imaging-based high cardiovascular risk in psoriasis: results from two observational cohorts. Eur J Prev Cardiol. 2022;29:591\u20138. https:\/\/doi.org\/10.1093\/eurjpc\/zwaa033.","journal-title":"Eur J Prev Cardiol"},{"key":"996_CR106","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","volume":"80","author":"CA Elmets","year":"2019","unstructured":"Elmets CA, Leonardi CL, Davis DMR, Gelfand JM, Lichten J, Mehta NN, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol. 2019;80:1073\u2013113. https:\/\/doi.org\/10.1016\/j.jaad.2018.11.058.","journal-title":"J Am Acad Dermatol"},{"key":"996_CR107","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1111\/jdv.19168","volume":"37","author":"A Svedbom","year":"2023","unstructured":"Svedbom A, St\u00e5hle M. The psoriasis area and severity index is an independent risk factor for cardiovascular events: a prospective register study. J Eur Acad Dermatol Venereol. 2023;37:1841\u20137. https:\/\/doi.org\/10.1111\/jdv.19168.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"996_CR108","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/acr.20627","volume":"63","author":"JA Husted","year":"2011","unstructured":"Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, et al. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res. 2011;63:1729\u201335. https:\/\/doi.org\/10.1002\/acr.20627.","journal-title":"Arthritis Care Res"},{"key":"996_CR109","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1038\/jid.2015.87","volume":"135","author":"R Parisi","year":"2015","unstructured":"Parisi R, Rutter MK, Lunt M, Young HS, Symmons DPM, Griffiths CEM, et al. Psoriasis and the risk of major cardiovascular events: cohort study using the clinical practice research datalink. J Invest Dermatol. 2015;135:2189\u201397. https:\/\/doi.org\/10.1038\/jid.2015.87.","journal-title":"J Invest Dermatol"},{"key":"996_CR110","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/acr.24578","volume":"74","author":"S Koppikar","year":"2022","unstructured":"Koppikar S, Colaco K, Harvey P, Akhtari S, Chandran V, Gladman DD, et al. Incidence of and risk factors for heart failure in patients with psoriatic disease: a cohort study. Arthritis Care Res. 2022;74:1244\u201353. https:\/\/doi.org\/10.1002\/acr.24578.","journal-title":"Arthritis Care Res"},{"key":"996_CR111","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-019-0875-0","volume":"22","author":"H Choi","year":"2019","unstructured":"Choi H, Uceda DE, Dey AK, Mehta NN. Application of non-invasive imaging in inflammatory disease conditions to evaluate subclinical coronary artery disease. Curr Rheumatol Rep. 2019;22:1. https:\/\/doi.org\/10.1007\/s11926-019-0875-0.","journal-title":"Curr Rheumatol Rep"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-025-00996-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-025-00996-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-025-00996-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:50:56Z","timestamp":1769849456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-025-00996-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["996"],"URL":"https:\/\/doi.org\/10.1007\/s40257-025-00996-y","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"8 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"J.T., M.P., R.M., A.S., C.C., F.T., and S.P. have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Ethical approval was not required for this study, as it is a review of previously published data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"No new data were created or analyzed in this study. Data sharing is not applicable to this article.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability (Software Application or Custom Code)"}},{"value":"Conceptualization, J.T. and M.P.; Methodology, F.T. and S.P.; Investigation, R.M., A.S., and C.C.; Writing\u2014original draft preparation, J.T., M.P., and C.C.; Writing\u2014review and editing, J.T. and A.S.; Supervision, S.P. All authors reviewed and approved the final version of the manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}